Chromosomal microarray analysis for pregnancies with abnormal maternal serum screening who undergo invasive prenatal testing

Recently, chromosomal microarray analysis (CMA) has been implemented as a first‐tier test in pregnancies with ultrasound anomalies. However, its application for pregnancies with abnormal maternal serum screening (AMSS) only is not widespread. This study evaluated the value of CMA compared to traditi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cell Mol Med
Autori principali: Wu, Xiaoqing, Li, Ying, Lin, Na, Xie, Xiaorui, Su, Linjuan, Cai, Meiying, Lin, Yuan, Wang, Linshuo, Wang, Meiying, Xu, Liangpu, Huang, Hailong
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2021
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256361/
https://ncbi.nlm.nih.gov/pubmed/34042265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16589
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi